Trials / Completed
CompletedNCT01302925
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate Gel Followed by Hand Washing in Healthy Subjects
PEP005 Gel - Evaluation of Local Tolerability After Exposure to Ingenol Mebutate 0.05% and 0.015% Gel Followed by Hand Washing in Healthy Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Peplin · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this phase 1 trial is to investigate the local tolerability on the finger following exposure to PEP005 Gel 0.015% or 0.05% and hand washing once daily, for 2 or 3 consecutive days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEP005 Gel | PEP005 Gel 0.05% for 2 consecutive days |
| DRUG | PEP005 Gel | PEP005 Gel 0.015% for 3 consecutive days |
Timeline
- Start date
- 2011-02-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2011-02-24
- Last updated
- 2015-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01302925. Inclusion in this directory is not an endorsement.